To evaluate, whether calreticulin expression increases the phagocytic efficacy of CD47 mAb therapy, we cocultured MNNG/HOS tumor cells with bone marrow‐derived M1 macrophages in presence of doxorubicin, CD47 mAb, and combination treatment. This evidence concerns the gene CD47 and neoplasm.